The Connectivity Map: a new tool for biomedical research
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The ultimate objective of biomedical research is to connect human diseases with the genes that underlie them and drugs that treat them. But this remains a daunting task, and even the most inspired researchers still have to resort to laborious screens of genetic or chemical libraries. What if at least some parts of this screening process could be systematized and centralized? And hits found and hypotheses generated with something resembling an internet search engine? These are the questions the Connectivity Map project set out to answer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, they do not support complex molecular readouts such as transcriptome profiling, which is one of the most comprehensive and informative measures of cellular response 5 .”
From Pooled CRISPR screening with single-cell transcriptome readout. (2017) · cites this paper as [5]
In the citing paper
“This tool allowed researchers to investigate genome-wide effects of GHK and establish that GHK-Cu is able to up- and down-regulate a significant number of human genes.”
From Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018) · cites this paper as [3]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243 · cited 1×
“) to rationality (chronic myeloid leukaemia–BCR-ABL–imatini”
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Cited by
Items 201–300 of 984
Circulating and imaging markers for angiogenesis
Pathak, A. P., Hochfeld, W. E., Goodman, S. L., & Pepper, M. S. (2008) · Angiogenesis · doi:10.1007/s10456-008-9119-z · Cited by 50
“Novel multidimensional “visualization” and “data-mining” tools such the proposed “connectivity map” will empower researchers to avoid oversimplifications and appreciate the information contained in these complex interactions [131].”
BackgroundDeubiquitinases as potential anti-cancer targets for gold(iii) complexes
Zhang, J., Ng, K., Lok, C., Sun, R. W., & Che, C. (2013) · Chemical Communications · doi:10.1039/c3cc41766b · Cited by 54
A sub-pathway-based approach for identifying drug response principal network
Chen, X., Xu, J., Huang, B., Li, J., Wu, X., Ma, L., Jia, X., Bian, X., Tan, F., Liu, L., et al. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq714 · Cited by 50
CD133 in brain tumor: the prognostic factor
Li, B., McCrudden, C. M., Yuen, H. F., Xi, X., Lyu, P., Chan, K. W., Zhang, S., & Kwok, H. F. (2016) · Oncotarget · doi:10.18632/oncotarget.14406 · Cited by 50
Noh, H., Shoemaker, J. E., & Gunawan, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1314 · Cited by 56
“A notable example of such an approach is the Connectivity Map (5), which provides gene expression profiles of human cell lines treated by ∼ 5000 small molecule compounds as queryable signatures for evaluating drug–drug similarities (6).”
BackgroundJin, G., Zhao, H., Zhou, X., & Wong, S. T. C. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr202 · Cited by 56
“They assert a long-term effect, called off-target effect (Keiser et al., 2009; Lamb, 2007; Lamb et al., 2006; MacDonald et al., 2006), on gene transcription-related molecules through the downstream signals along the pathway.”
BackgroundSystems healthcare: a holistic paradigm for tomorrow
Fiandaca, M. S., Mapstone, M. E., Connors, E. E., Jacobson, M., Monuki, E. S., Malik, S., Macciardi, F. M., & Federoff, H. J. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0521-2 · Cited by 53
Pickart, L., Vasquez-Soltero, J., & Margolina, A. (2015) · Cosmetics · doi:10.3390/cosmetics2030236 · Cited by 48
“used a repository of transcriptional responses to compounds, the Connectivity Map (cMap) [16], and MANTRA software (www.”
MethodNiu, Q., Li, H., Tong, L. X., Liu, S., Zong, W., Zhang, S., Tian, S., Wang, J., Liu, J. H., Li, B., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad102 · Cited by 50
Er, J. L., Goh, P. N., Lee, C. Y., Tan, Y. J., Hii, L., Mai, C., Chung, F. F., & Leong, C. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1459-6 · Cited by 50
Amadoz, A., Sebastián-León, P., Vidal, E., Salavert, F., & Dopazo, J. (2015) · Scientific Reports · doi:10.1038/srep18494 · Cited by 47
Identifying key genes in rheumatoid arthritis by weighted gene co‐expression network analysis
Ma, C., Lv, Q., Teng, S., Yu, Y., Niu, K., & Yi, C. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13063 · Cited by 49
Li, F., He, B., Ma, X., Yu, S., Bhave, R. R., Lentz, S. R., Tan, K., Guzmán, M. L., Zhao, C., & Xue, H. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.08.001 · Cited by 48
“The Connectivity Map (CMAP) database can be queried with a gene signature of interest to identify those compounds that induce desired gene expression changes (Lamb, 2007).”
MethodExposure to GenX and its novel analogs disrupts fatty acid metabolism in male mice
Guo, H., Sheng, N., Guo, Y., Wu, C., Xie, W., & Dai, J. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.118202 · Cited by 47
Salient experiences are represented by unique transcriptional signatures in the mouse brain
Mukherjee, D., Ignatowska-Jankowska, B. M., Itskovits, E., Gonzales, B. J., Turm, H., Izakson, L., Haritan, D., Bleistein, N., Cohen, C., Amit, I., et al. (2018) · eLife · doi:10.7554/elife.31220 · Cited by 46
“, 2016), diseases (Lamb, 2007; McKinney et al., 2010), and many other aspects of contemporary biomedical science (Collins and Varmus, 2015).”
BackgroundMethodFan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04516-6 · Cited by 49
“The connectivity map was analyzed on Connectivity Map (https:// clue. io) [19, 20] with default settings.”
MethodHuman Lymphoblastoid Cell Line Panels: Novel Tools for Assessing Shared Drug Pathways
Morag, A., Kirchheiner, J., Rehavi, M., & Gurwitz, D. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.27 · Cited by 46
Mining a human transcriptome database for chemical modulators of NRF2
Rooney, J. P., Chorley, B. N., Hiemstra, S. W., Wink, S., Wang, X., Bell, D. A., van de Water, B., & Corton, J. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239367 · Cited by 49
“The CMAP project screened ~1300 small molecules in 3 cell lines with whole transcriptome expression data [7, 8].”
Crouchet, É., Bandiera, S., Fujiwara, N., Li, S., Saghire, H. E., Fernández-Vaquero, M., Riedl, T., Sun, X., Hirschfield, H., Jühling, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25468-9 · Cited by 50
Kwong, W., Sun, R. W., Lok, C., Siu, F., Wong, S.-Y., Low, K., & Che, C. (2012) · Chemical Science · doi:10.1039/c2sc21541a · Cited by 51
Dissecting Traditional Chinese Medicines by Omics and Bioinformatics
Quan, Y., Wang, Z., Xiong, M., Xiao, Z., & Zhang, H. (2014) · Natural Product Communications · doi:10.1177/1934578x1400900942 · Cited by 45
“The Connectivity Map (cMap) is a collection of microarray expression data from cultured human cells treated with bioactive small molecules [15].”
BackgroundYu, L., Zhao, J. K., & Gao, L. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.03.009 · Cited by 45
DAPK1 as an independent prognostic marker in liver cancer
Li, L., Guo, L., Wang, Q., Liu, X., Zeng, Y., Wen, Q., Zhang, S., Kwok, H. F., Lin, Y., & Liu, J. (2017) · PeerJ · doi:10.7717/peerj.3568 · Cited by 46
“Gene expression connectivity mapping was performed to identify candidate small molecule compounds that may reverse the reduced expression of DAPK1 and its associated gene expression signature using a statistically significant connections’ map (sscMap) as previously described (Lamb, 2007; Lamb et al., 2006; Zhang & Gan…”
MethodZeng, F., Zhang, Y., Han, X., Zeng, M., Gao, Y., & Weng, J. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.033 · Cited by 51
“The Connectivity Map (CMap) is a database based on gene expression developed by the Broad Institute, which is mainly used to reveal the functional connection between small molecule compounds, genes and disease states [28,29].”
MethodTan, F., Yang, R., Xu, X., Chen, X., Wang, Y., Ma, H., Liu, X., Wu, X., Chen, Y., Liu, L., et al. (2014) · Molecular BioSystems · doi:10.1039/c3mb70554d · Cited by 50
Alaimo, S., Bonnici, V., Cancemi, D., Ferro, A., Giugno, R., & Pulvirenti, A. (2015) · BMC Systems Biology · doi:10.1186/1752-0509-9-s3-s4 · Cited by 51
“Another example of network based drug study is shown in Iorio et al. [3], where drug mode of action and drug repositioning are assessed using available gene expression profiles [4] to build a drug-drug network.”
BackgroundMethodPolypharmacology in Drug Development: A Minireview of Current Technologies
Tan, Z., Chaudhai, R., & Zhang, S. (2016) · ChemMedChem · doi:10.1002/cmdc.201600067 · Cited by 49
Old drugs, new uses: Drug repurposing in hematological malignancies
Kale, V. P., Habib, H., Chitren, R. J., Patel, M., Pramanik, K. C., Jonnalagadda, S. C., Challagundla, K. B., & Pandey, M. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.005 · Cited by 52
Composition and applications of focus libraries to phenotypic assays
Wassermann, A. M., Camargo, L. M., & Auld, D. S. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00164 · Cited by 42
“…for the assembly of such a library was to select a chemically maximally diverse compound set using diversity measures based on molecular scaffolds (Krier et al., 2006), physicochemical properties, 2D and 3D chemical structure (Matter, 1997), or pharmacophore descriptors (Mason et al., 2001).”
BackgroundIorio, F., Shrestha, R. L., Levin, N., Boilot, V., Garnett, M. J., Sáez-Rodríguez, J., & Draviam, V. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139446 · Cited by 46
“…specific ones such as the Con-nectivity-map (a data-set of expression profiles derived from treatments with a large number of drugs on a set of human cell lines) (cMap) [4], it has been possible to infer new potential therapeutic applications for already approved drugs (drug-repositioning) [5].”
BackgroundDiscovery of Herbacetin as a Novel SGK1 Inhibitor to Alleviate Myocardial Hypertrophy
Zhang, S., Wang, Y., Yu, M., Shang, Y., Chang, Y., Zhao, H. L., Kang, Y., Zhao, L., Xu, L., Zhao, X., et al. (2021) · Advanced Science · doi:10.1002/advs.202101485 · Cited by 44
Huang, L., Zhao, S., Frasor, J. M., & Dai, Y. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022274 · Cited by 43
“The current version of the Connectivity Map (build 02) contains 6,100 such instances representing 5 cultured human cell lines treated with 1,309 compounds.”
MethodInfluentialIdentification of potential endocrine disrupting chemicals using gene expression biomarkers
Corton, J. C., Kleinstreuer, N., & Judson, R. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114683 · Cited by 47
Maas, A.-M., Bretz, A. C., Mack, E., & Stiewe, T. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.030 · Cited by 46
“tical drugs [93,94].”
Lawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 59
Cheng, H.-M., Li, C., Chen, C. Y., Lo, H., Cheng, W.-Y., Lee, C.-H., Yang, S.-Z., Wu, S., Hsiang, C., & Ho, T. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.08.022 · Cited by 43
A pharmacogenomic method for individualized prediction of drug sensitivity
Cohen, A. L., Soldi, R., Zhang, H., Gustafson, A. M., Wilcox, R., Welm, B. E., Chang, J. T., Johnson, W. E., Spira, A. E., Jeffrey, S. S., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.47 · Cited by 46
Tseng, A. H., Yang, C.-H., Chen, C., Chen, C.-H., Hsu, S., Lee, M., Lee, H.-C., & Su, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4441 · Cited by 43
“LINCS or the Library or Integrated Network-based Cellular Signatures project is the extensive version of CMAP (29) which is available on the http://lincscloud.org website.”
BackgroundPrediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk
Yu, L., Su, R., Wang, B., Zhang, L., Zou, Y., Zhang, J., & Gao, L. (2016) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2016.2550453 · Cited by 42
“The Connectivity Map (Cmap) is one of the most comprehensive and systematic approaches for drug-disease relationships [15].”
BackgroundDoxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells
Alexander‐Savino, C. V., Hayden, M. S., Richardson, C. T., Zhao, J., & Poligone, B. (2016) · Oncotarget · doi:10.18632/oncotarget.12488 · Cited by 44
“The “Connectivity Map” is a research effort of the Broad Institute that links gene expression patterns produced after treatment with over 1,300 small-molecule compounds [14].”
BackgroundAl‐Natour, B., Rankin, R., McKenna, R., McMillan, H. P., Zhang, S., About, I., khan, A. W. A., Galicia, J. C., Lundy, F. T., & Karim, I. A. E. (2021) · International Endodontic Journal · doi:10.1111/iej.13547 · Cited by 46
“The technique is employed for drug repositioning approaches (Lamb, 2007) and further developed into the ‘statistically significant connectivity map’ (ssCMap) by using statistical means to control for false connections between gene signature and reference profiles (Musa et al., 2018; Zhang & Gant,…”
MethodBeck, A. H., West, R. B., & van de Rijn, M. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0774-2 · Cited by 42
“A gene expression meta-analysis utilizing these datasets in conjunction with novel bioinformatics analytic techniques [15, 85–91] may prove useful for more fully understanding the aberrant biological pathways contributing to sarcomagenesis and for identifying and designing effective drugs to treat these conditions.”
Screening and identification of novel biologically active natural compounds
Newman, D. J. (2017) · F1000Research · doi:10.12688/f1000research.11221.1 · Cited by 41
In�silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme
Xiong, D., Xu, W., He, R., Dang, Y., Chen, G., & Luo, D. (2019) · Oncology Reports · doi:10.3892/or.2019.7022 · Cited by 45
Tu, Z., Ouyang, Q., Long, X., Wu, L., Li, J., Zhu, X., & Huang, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.837512 · Cited by 45
Yauk, C. L., Buick, J. K., Williams, A., Swartz, C. D., Recio, L., Li, H., Fornace, A. J., Thomson, E. M., & Aubrecht, J. (2016) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22004 · Cited by 42
“Higher throughput approaches for transcriptional profiling are being developed, and it is likely that in vitro global gene expression analysis will become a first screen to predict potential adverse health effects and modes of action for chemicals in the future [Lamb et al., 2006; Lamb, 2007; Patlewicz et al., 2013; Z…”
BackgroundVilar, S., & Hripcsak, G. M. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw048 · Cited by 51
Khunsriraksakul, C., McGuire, D., Sauteraud, R., Chen, F., Yang, L., Wang, L., Hughey, J. M., Eckert, S., Weissenkampen, J. D., Shenoy, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30956-7 · Cited by 45
Chemical-induced gene expression ranking and its application to pancreatic cancer drug repurposing
Pham, T.-H., Qiu, Y., Liu, J., Zimmer, S., O’Neill, E. E., Xie, L., & Zhang, P. (2022) · Patterns · doi:10.1016/j.patter.2022.100441 · Cited by 46
Making sense out of massive data by going beyond differential expression
Schmid, P. R., Palmer, N., Kohane, I. S., & Berger, B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118792109 · Cited by 39
“Even recent large-scale gene expression investigations, whether they have attempted to elucidate phenotypic signals (5–7) or applied those signals for downstream analyses such as drug repurposing (8, 9), involve comparisons between two states or classes.”
BackgroundPolypharmacology Shakes Hands with Complex Aetiopathology
Brodie, J., Marzo, V. D., & Guy, G. W. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.010 · Cited by 38
Diaz, J. E. L., Ahsen, M. E., Schaffter, T., Chen, X., Realubit, R. B., Karan, C., Califano, A., Losic, B., & Stolovitzky, G. A. (2020) · eLife · doi:10.7554/elife.52707 · Cited by 40
Wang, C., Chao, Y., Chen, Y., Wang, T.-W., Phan, N. N., Hsu, H., Shan, Y., & Lai, M.-D. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.48123 · Cited by 38
“To reveal meaningful biological connections of the gene list, the gene-signature perturbation approach was performed in the present study [33,34].”
MethodSilveira, A. B., Laranjeira, A. B. A., Rodrigues, G. O. L., Leal, P. C., Cardoso, B. A., Barata, J. T., Yunes, R. A., Zanchin, N. I. T., Brandalise, S. R., & Yunes, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.3524 · Cited by 37
“org/cmap/) [67], only probesets identical in HG-U133A and HG-U133 Plus 2.”
BackgroundMousavi, S. Z., Rahmanian, M., & Sami, A. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104610 · Cited by 39
“The CMap is a collection of gene-expression profiles of drug-treated human cancer cells, which has been widely used for investigation of polypharmacology and drug repurposing [6, 7].”
CeDR Atlas: a knowledgebase of cellular drug response
Wang, Y., Kang, H., Xu, T., Hao, L., Bào, Y., & Jia, P. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab897 · Cited by 40
Hoyt, M. T., Palchaudhuri, R., & Hergenrother, P. J. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9390-x · Cited by 37
“The analysis of global transcriptional changes in response to compound treatment can be used to identify cellular pathways affected by a small molecule, and in some cases can suggest a macromolecular target [55–57].”
BackgroundSpironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
Gold, A., Eini, L., Nissim‐Rafinia, M., Viner‐Breuer, R., Ezer, S., Erez, K., Aqaqe, N., Hanania, R., Milyavsky, M., Meshorer, E., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0654-9 · Cited by 37
Gut microbiota and tuberculosis
Liu, Y., Yang, L., Meskini, M., Goel, A., Opperman, M., Shyamal, S. S., Manaithiya, A., Xiao, M., Ni, R., An, Y., et al. (2025) · iMeta · doi:10.1002/imt2.70054 · Cited by 43
Use of big data in drug development for precision medicine
Kim, R. S., Goossens, N., & Hoshida, Y. (2016) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2016.1174062 · Cited by 41
“Transcriptome is increasingly recognized as a common space, where the functional consequence of various types of molecular dysregulations and aberrations as well as drug treatment can be directly compared and linked based on the similarity of transcriptional changes measured as gene signatures [48].”
BackgroundSerra, A., Letunić, I., Fortino, V., Handy, R. D., Fadeel, B., Tagliaferri, R., & Greco, D. (2019) · Scientific Reports · doi:10.1038/s41598-018-37411-y · Cited by 42
Jiang, P., Cao, Y., Gao, F., Sun, W., Liu, J., Ma, Z., Xie, M., & Fu, S. (2021) · BMC Cancer · doi:10.1186/s12885-021-08212-w · Cited by 39
Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors
Kortenhorst, M. S. Q., Wissing, M. D., Rodríguez, R., Kachhap, S. K., Jans, J. J. M., van der Groep, P., Verheul, H. M. W., Gupta, A. K., Aiyetan, P., van der Wall, E., et al. (2013) · Epigenetics · doi:10.4161/epi.25574 · Cited by 37
“In the Connectivity Map PC3 cells had been treated with various HDACis at various dosages for 6 h.(17) A detailed description of these data sets is available in the Supplemental Materials and http://luigimarchionni.”
MethodInfluentialGenetic and proteomic approaches to identify cancer drug targets
Roti, G., & Stegmaier, K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.543 · Cited by 41
“Expanding on this idea, Lamb et al developed the Connectivity Map (C-Map), the first mammalian compendium of chemically perturbed transcriptional profiles, as an in silico tool for signaturebased small-molecule and target discovery (Lamb et al, 2006; Lamb, 2007; Palchaudhuri and Hergenrother, 2011).”
MethodHuang, C., Chang, P. M., Hsu, C.-W., Huang, C. F., & Ng, K. (2016) · BMC Bioinformatics · doi:10.1186/s12859-015-0845-0 · Cited by 38
“The FC value of any gene expression level with a fold change value of less than 5.64 was set to 5.64 to facilitate the cMap [29] search.”
MethodInfluentialYamada, R., Cao, X., Butkevich, A. N., Millard, M., Odde, S., Mordwinkin, N., Gundla, R., Zandi, E., Louie, S. G., Petasis, N. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101655d · Cited by 36
Identification of repaglinide as a therapeutic drug for glioblastoma multiforme
Xiao, Z. X., Chen, R. Q., Hu, D. X., Xie, X. Q., Yu, S., & Chen, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.157 · Cited by 36
Chen, R., Mallelwar, R., Thosar, A., Venkatasubrahmanyam, S., & Butte, A. J. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-548 · Cited by 35
“The Connectivity Map [4] identifies expression profiles of different cell lines after perturbation by a catalog of small molecule drugs.”
BackgroundSystematic Quality Control Analysis of LINCS Data
Cheng, L., & Li, L. (2016) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12107 · Cited by 39
“…drug screens for anticancer projects, such as the National Cancer Institute 60 (NCI60) human tumor cell line panel, 1 Connectivity Map (CMAP), 2,3 Cancer Cell Line Encyclopedia (CCLE), 4 Genomics of Drug Sensitivity in Cancer (GDSC), 5 and the cancer therapeutics response portal (CTRP) 6 all…”
BackgroundXiao, Z., Shen, J., Zhang, L., Li, M., Hu, W., & Cho, C. H. (2018) · Oncology Letters · doi:10.3892/ol.2018.7758 · Cited by 36
“A powerful online database, The Connectivity Map, which uses gene-expression signatures to connect small molecules, genes, and disease (77,78), has provided a novel way to identify potential modulators of sncRNAs for cancer therapy.”
BackgroundDrug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses
Amemiya, T., Gromiha, M. M., Horimoto, K., & Fukui, K. (2019) · Scientific Reports · doi:10.1038/s41598-018-36636-1 · Cited by 35
Lost in application: Measuring hypoxia for radiotherapy optimisation
Thiruthaneeswaran, N., Bibby, B. A. S., Yang, L., Hoskin, P., Bristow, R. G., Choudhury, A., & West, C. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.039 · Cited by 37
Immune Microenvironment and Response in Prostate Cancer Using Large Population Cohorts
Ren, X., Chen, X., Zhang, X., Jiang, S., Zhang, T., Li, G., Lü, Z., Zhang, D., Wang, S., & Qin, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686809 · Cited by 36
“Candidate Compounds Targeting the IRS Signature Based on CMap Analysis CMap analysis screens potential compounds and drugs by investigating the changes in genes between different groups, based on a comprehensive and well-curated data resource (26).”
BackgroundGenome-Scale Screening of Drug-Target Associations Relevant to Ki Using a Chemogenomics Approach
Cao, D., Liang, Y., Deng, Z., Hu, Q., He, M., Xu, Q., Zhou, G., Zhang, L., Deng, Z., & Liu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057680 · Cited by 39
“Detecting such interactions may need the development of specific modeling approaches [12,56,57,58].”
BackgroundThe opportunities of mining historical and collective data in drug discovery
Wassermann, A. M., Lounkine, E., Davies, J. W., Glick, M., & Camargo, L. M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.004 · Cited by 34
High-Throughput Gene Expression Profiles to Define Drug Similarity and Predict Compound Activity
Wolf, H. D., Cougnaud, L., Hoorde, K. V., Bondt, A. D., Wegner, J. K., Ceulemans, H., & Göhlmann, H. W. H. (2018) · Assay and Drug Development Technologies · doi:10.1089/adt.2018.845 · Cited by 35
Li, C., Chen, Y., Zhu, H.-T., Zhang, X., Han, L., Zhao, Z., Wang, J., Ning, L., Zhou, W., Lü, C., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa016 · Cited by 36
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
Yang, C. Z., Hou, K., Wang, Y., Chen, Y., Zheng, X., Qi, J., Yang, B., Tang, S., Han, X., Shi, D., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.665276 · Cited by 40
McArt, D. G., & Zhang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016382 · Cited by 35
Montero‐Melendez, T., Dalli, J., & Perretti, M. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.154 · Cited by 35
“A novel approach to drug discovery, the Connectivity Map (CMap), proposed by Lamb et al.(9,10) and recently validated by Sirota et al.”
Ji, R., de Silva, H., Jin, Y., Bruccoleri, R. E., Cao, J., He, A., Huang, W., Kayne, P. S., Neuhaus, I. M., Ott, K., et al. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000512 · Cited by 35
“Transcriptional profiling provides an informative genomewide view of biological responses [17], thus obtaining quantitative dose-response information for transcript responses has obvious application in characterizing compounds that have high potential to interact with multiple targets.”
BackgroundSpijkers-Hagelstein, J. A. P., Pinhanços, S. S., Schneider, P., Pieters, R., & Stam, R. W. (2013) · Leukemia · doi:10.1038/leu.2013.245 · Cited by 34
A generalizable pre-clinical research approach for orphan disease therapy
Beaulieu, C. L., Samuels, M. E., Ekins, S., McMaster, C. R., Edwards, A. M., Krainer, A. R., Hicks, G. G., Frey, B. J., Boycott, K. M., & MacKenzie, A. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-39 · Cited by 38
Hsiang, C., Chen, Y.-S., & Ho, T. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.016 · Cited by 33
“Connectivity Map is a method that compares lists of differential expressed genes to a library of experiments assessing the effects of small molecules and genetic events on gene expression [19,29].”
MethodGrafström, R., Nymark, P. E. H., Hongisto, V., Spjuth, O., Ceder, R., Willighagen, E., Hardy, B. J., Kaski, S., & Kohonen, P. J. (2015) · Alternatives to Laboratory Animals · doi:10.1177/026119291504300506 · Cited by 34
Pang, X., Zhao, Y., Wang, J., Zhou, Q., Xu, L., Kang, D., Liu, A., & Du, G. (2017) · BioMed Research International · doi:10.1155/2017/9084507 · Cited by 37
“The gene expression profiles on AD and control (CT) samples from Gene Expression Omnibus (GEO) database [9] were downloaded, and then the DEGs in EC and HIP regions were analyzed for functional and pathway enrichment analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) to elucidate the pat…”
MethodThe Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources
Mathé, E. A., Hays, J. L., Stover, D. G., & Chen, J. L. (2018) · Yearbook of Medical Informatics · doi:10.1055/s-0038-1667085 · Cited by 38
“, the Connectivity Map project [165]) and from a patient’s electronic health record (EHR) to separate patient’s EHRs [166].”
A Systems Toxicology Approach for the Prediction of Kidney Toxicity and Its Mechanisms In Vitro
Ramm, S., Todorov, P. V., Chandrasekaran, V., Dohlman, A. B., Monteiro, M. B., Pavkovic, M., Muhlich, J. L., Shankaran, H., Chen, W. W., Mettetal, J. T., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz021 · Cited by 34
“These transcripts, called L1000, represent a selection of landmark genes characteristic of the variability of the transcriptome (Adler et al., 2016; Lamb, 2007).”
BackgroundRepurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
Truong, T. T. T., Panizzutti, B., Kim, J. H., & Walder, K. R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071464 · Cited by 37
“Genome/Transcriptome GWAS (general): GWAS ATLAS [60] NCBI Database of Genotypes and Phenotypes (dbGaP) [61] GWAS (psychiatry): NIMH Repository and Genomics Resource (NRGR) [62] Psychiatric Genomics Consortium (PGC) [63] Autism Sequencing Consortium (ASC) [64] Whole-Genome Sequencing Consortium for Psychiatric Disorder…”
BackgroundLai, C.-Y., Yeh, D., Lu, C.-H., Liu, Y., Huang, L.-R., Kao, C., Chen, H., Huang, C. F., Chang, C., Luo, Y., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500194 · Cited by 33
“This database enables the discovery of functionally similar chemicals through comparisons of the gene expression profiles of cells treated with these chemicals (35, 36).”
BackgroundProstate cancer regulatory networks
Altieri, D. C., Languino, L. R., Lian, J. B., Stein, J. L., Leav, I., van Wijnen, A. J., Jiang, Z., & Stein, G. S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22162 · Cited by 34
“, 2006] linking together multiple signaling mechanisms of tumor maintenance [Lamb, 2007], may more faithfully recapitulate the ‘‘tumor tactics’’ [Kitano, 2003] responsible for treatment failure, including pathway redundancy, buffering, and modularity into semi-autonomous sub-networks [Butcher, 2005; Rajasethupathy et…”
BackgroundNew Perspectives for the Rescue of Cognitive Disability in Down Syndrome
Bartesaghi, R., Haydar, T. F., Delabar, J. M., Dierssen, M., Martínez‐Cué, C., & Bianchi, D. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2775-15.2015 · Cited by 34
Anticancer dirhodium(ii,ii) carboxylates as potent inhibitors of ubiquitin-proteasome system
Siu, F., Lin, I. W., Yan, K., Lok, C., Low, K., Leung, T. Y.-C., Lam, T. L., & Che, C. (2012) · Chemical Science · doi:10.1039/c2sc00620k · Cited by 33
Ling, Y., Chen, J., Guo, L., Wang, C.-Y., Tan, W., Wen, Q., Zhang, S., Deng, G., Lin, Y., & Kwok, H. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-13332-0 · Cited by 32
Peart, T. M., Correa, R. J. M., Valdés, Y. R., DiMattia, G. E., & Shepherd, T. G. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9451-3 · Cited by 36
Drug target inference through pathway analysis of genomics data
Ma, H., & Zhao, H. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.12.004 · Cited by 34
“The Connectivity Map project initiated by the Broad Institute went a step further [31,32].”
Computational estimation of quality and clinical relevance of cancer cell lines
Trastulla, L., Noorbakhsh, J., Vazquez, F., McFarland, J., & Iorio, F. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211017 · Cited by 31
“In addition, CCL-based post-perturbational transcriptomic data sets such as the Connectivity Map (Lamb, 2007; Bush et al , 2017; Ye et al , 2018) and related Web resources (Stathias et al , 2020) have been pivotal for computational drug discovery and repositioning (Pushpakom et al , 2018), and are…”
MethodPalchaudhuri, R., & Hergenrother, P. J. (2010) · ACS Chemical Biology · doi:10.1021/cb100310h · Cited by 31
“Using disease- or physiological process-specific signatures as the query, small molecules in the Connectivity Map database that have positive or negative correlations can be readily identified (Figure 3) (9, 10).”
BackgroundMethodChen, J., Hsieh, Y., Lo, H.-L., Li, A., Chou, C.-J., & Yang, P. (2019) · Biomolecules · doi:10.3390/biom9090467 · Cited by 31
“By mining and comparing the queried and existing gene signatures, one can find connections among genetic knockdown/overexpression or small molecules with similar action mechanisms [8,27,28].”
BackgroundLane, T. R., Urbina, F., Rank, L., Gerlach, J., Riabova, O., Lepioshkin, A., Kazakova, E., Vocat, A., Tkachenko, V., Cole, S. T., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00791 · Cited by 32
Metadata
- Authors
- Lamb, J.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Venue
- Nature Reviews Cancer
- Published
- 2007-01
- Volume
- 7
- Issue
- 1
- Pages
- 54-60
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2029980980
- Semantic Scholar
- d1610ee5045d33be16a9a72a514fea537ba46306
- Cited by
- 945
- References
- 66
- Citations by year
- 2026: 11 · 2025: 29 · 2024: 75 · 2023: 54 · 2022: 56 · 2021: 100 · 2020: 79 · 2019: 64 · 2018: 60 · 2017: 52 · 2016: 58 · 2015: 57 · 2014: 42 · 2013: 49 · 2012: 56
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Broad Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene-disease association, drug repurposing, gene expression profiling, cancer research, drug discovery
- MeSH terms
- Algorithms, Animals, Gene Expression Regulation, Humans, Information Services, Models, Biological, Models, Genetic, Neoplasms, Phenotype, Software, Information Storage and Retrieval, Genome, Computational Biology, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.